Company Encyclopedia
View More
name
FENGBEI BIOTECH
603334.SH
Suzhou Fengbei Biotech Stock Co., Ltd. manufactures and sells resource-based products from utilization of natural oil and fat resources in China. It offers bio-based materials for use in pesticides, fertilizers, mineral processing, ink resins, textiles, biopharmaceuticals, and other fields; biofuels; and oleochemicals, such as DD oil, fatty acids, etc. The company was founded in 2014 and is based in Zhangjiagang, China.
3.085 T
603334.SHMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Chinese Shares Rise as US Trims Tariffs; Fengbei Biotech Up 173% in Shanghai Debut

    Chinese Shares Rise as US Trims Tariffs; Fengbei Biotech Up 173% in Shanghai Debut

    marketscreener·
    SH
    603334
    -1.62%
    marketscreener·
    SH
    603334
    -1.62%

    FENGBEI BIOTECH stock will be listed on the Shanghai Stock Exchange main board on November 5

    According to the Zhitong Finance APP, FENGBEI BIOTECH announced that its stock will be listed on the main board of the Shanghai Stock Exchange on November 5, 2025

    Zhitong·
    SH
    603334
    -1.62%
    Zhitong·
    SH
    603334
    -1.62%

    FENGBEI BIOTECH: 35.9 million new shares will be listed on the main board on November 5, highlighting multiple risks

    FENGBEI BIOTECH announced that its 35.9 million new shares will be listed on the Shanghai Stock Exchange main board on November 5, 2025, with the stock code 603334. The company reminds investors to pay attention to various risks in the early stages of listing, including the relaxation of price fluctuation limits, low circulating shares, valuation, and margin financing risks. The issuance price is set at 24.49 yuan per share, corresponding to a diluted price-to-earnings ratio of 30.47 times for 2024 after deducting non-recurring items, which is lower than the industry average and the average level of comparable companies

    Zhitong·
    SH
    603334
    -1.62%
    Zhitong·
    SH
    603334
    -1.62%

    New Stock Alert: FENGBEI BIOTECH is available for subscription today

    Today, FENGBEI BIOTECH is available for subscription, with an issuance price-to-earnings ratio of 30.47 times, subscription code 732334, subscription price of 24.49 yuan, and a single account subscription limit of 11,000 shares

    Zhitong·
    SH
    603334
    -1.62%
    Zhitong·
    SH
    603334
    -1.62%

    A-share subscription | FENGBEI BIOTECH starts subscription with existing biodiesel production capacity of 105,000 tons

    FENGBEI BIOTECH started its subscription on October 27, with an issue price of 24.49 yuan per share, a subscription limit of 11,000 shares, and a price-to-earnings ratio of 30.47 times. The company focuses on the comprehensive utilization of waste oil resources, with an existing biodiesel production capacity of 105,000 tons, ranking sixth in the industry. From 2022 to 2024, the company's operating revenues are projected to be 1.709 billion yuan, 1.728 billion yuan, and 1.948 billion yuan, with net profits of 133 million yuan, 130 million yuan, and 124 million yuan, respectively. The net cash flow from operating activities is expected to decline in 2024

    Zhitong·
    SH
    603334
    -1.62%
    Zhitong·
    SH
    603334
    -1.62%
    © 2025 Longbridge｜Disclaimer